Zurn Elkay (NYSE:ZWS) Posts Better
Zurn Elkay (NYSE:ZWS) reported Q2 CY2026 results. Revenue rose 10.5% year on year to $491 million and exceeded Wall Street estimates by 1.6%. Non-GAAP profit was $0.50 per share, 5.8% above consensus. The company said it is raising its full-year outlook and repurchased $50 million of shares in the quarter.
How this was made
The 30-second read
Why it matters
The key new information is the Q2 beat (revenue and adjusted EPS) alongside management raising the full-year outlook, plus margin expansion and capital return activity (buybacks and dividends).
Market read
A Q2 beat with an outlook raise typically drives near-term estimate revisions and can sustain post-earnings momentum if the guidance change is meaningful.
What to watch
The text highlights EPS dilution over five years and does not quantify the size of the outlook raise, so traders should verify the updated guidance details and any one-time items behind margins.
Background
Zurn Elkay is a water management solutions provider, and the article frames its Q2 performance versus Wall Street expectations and its longer-term growth/margin trends.
Ticker impact
Zurn Elkay reported Q2 CY2026 revenue up 10.5% to $491M and adjusted EPS $0.50, beating consensus, and raised full-year outlook.
Likely supports continued upward bias versus prior expectations, though magnitude depends on how much the raised outlook changes full-year consensus.
The article provides specific Q2 results (revenue, adjusted EPS) and states management is raising full-year outlook, which are direct drivers for estimate revisions and trading.
Market effects
Improved margins and demand resilience in water management/industrial products can modestly support sentiment for industrials with similar end-markets.
No specific regional demand or macro linkage provided.
No explicit global supply chain or international demand details beyond currency/organic framing.
Counterpoint
Despite the beat, the article notes analysts expect revenue growth to decelerate to 4.7% over the next 12 months, which could cap upside.
Key entities
- public_companyZurn Elkay
Reported Q2 CY2026 revenue growth, adjusted EPS beat, and raised full-year outlook; also disclosed buyback and dividend payments.
